Heat­ed oral ar­gu­ments at SCO­TUS hint at Sanofi-Re­gen­eron edge over Am­gen in patent spat

WASH­ING­TON — Lawyers for Sanofi-Re­gen­eron, Am­gen, and the fed­er­al gov­ern­ment took the stage at the Supreme Court on Mon­day, ar­gu­ing a com­pli­cat­ed patent case over the two sides’ com­pet­ing, block­buster PC­SK9 in­hibitors with jus­tices’ ques­tions hint­ing at a de­ci­sion that will like­ly be a win for Sanofi and Re­gen­eron.

The morn­ing opened with about 45 min­utes for Am­gen’s lawyer, Jef­frey Lamken, who was pep­pered with straight­for­ward ques­tions from As­so­ciate Jus­tices Clarence Thomas and So­nia So­tomay­or, with Thomas at one point ask­ing, “I’m con­fused as to what your in­ven­tion is?”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER